Covid-19 vaccine developed in China shows promising results in early human trials: Report

Hindustan Times | May 23, 2020 at 6:17 AM
  • Researchers say that a vaccine developed in China, that has reached phase one clinical trial appears to be safe and may protect people from the coronavirus.
  • In the trial, those who received a single dose of the vaccine produced certain immune cells, called T cells.
  • The next phase, the second in the typical three phases of trials that a vaccine goes through, involves enrolling up to 10,260 adults and children to assess the immune response to the vaccine in people of different ages and assess if there is a variation.